Archive for October 2022
Citizens Business Conditions Index rebounded in third quarter, with employment going strong
Citizens’ index has spent eight consecutive quarters above 50, indicating continued growth. Read More
Read MoreMass CPAs, Charles River Regional Chamber urge ‘no’ vote on Ballot Question 1
Two weeks before Election Day, the Massachusetts Society of CPAs and the Charles River Regional Chamber have come out against the proposed tax increase in Ballot Question 1. Read More
Read MoreBoston cybersecurity company lays off nearly 200 employees
This company is laying off nearly 200 employees, or 14% of its workforce, in its second round of layoffs this year. Read More
Read MoreCambridge scraps parking minimums for commercial, housing developments
Cambridge’s city council voted Monday to scrap parking minimums, but there’s uncertainty about how it will affect the production of affordable housing. Read More
Read MoreBiogen paints an optimistic picture ahead of critical FDA decision
Biogen Inc. on Tuesday laid out an optimistic picture for analysts and investors, even as questions remain around its new Alzheimer’s drug and its leadership team. Read More
Read MoreThis startup is turning a horse IUD into more painless birth control for humans
A new type of IUD, which was first created by a veterinarian for use in horses, aims to reduce the pain points in the insertion and removal process. The company recently raised an early-stage funding round to advance the technology. Read More
Read MoreBizSpotlight: Nuveen Green Capital
Nuveen Green Capital is a national leader in susta Read More
Read MoreThree takeaways from Raytheon’s Q3 earnings call
The defense contractor Raytheon, which recently completed its move to Virginia but still has significant presence in Mass., held its 3rd quarter earnings call Tuesday. Here’s what the company’s saying about the war in Ukraine, commercial aviation and the impact of the move on the Bay State. Read More
Read MoreBayer, BMS veteran heads up new startup founded by one of immuno-oncology’s most prolific scientists
A new startup called Normunity Inc. is working on drugs based on a potentially breakthrough biotechnology: breaking down walls that prevent the body’s immune system from getting inside and attacking solid tumors. Read More
Read MoreA big Meta investor is urging Mark Zuckerberg to cut 20% of his workforce and slash metaverse spending in half
Meta needs to regain the confidence of investors and focus its business efforts, the CEO of Boston- and Bay Area-based Altimeter Capital Management. Read More
Read More